Contrast-enhanced breast MRI may help rule out malignancy and avoid surgery in patients with high-risk lesions, a systematic review and meta-analysis reveals.

According to the ARRS American Journal of Roentgenology (AJR), contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with ...

CHICAGO--(BUSINESS WIRE)--Contrast-enhanced ultrasound (CEUS) is more accurate and reliable than MRI for examining certain liver and kidney nodules, according to two new studies published in the ...

Leesburg, VA, September 14, 2022—According to ARRS’ American Journal of Roentgenology (AJR), the contrast-enhanced in-phase Dixon sequence could reduce the need for correlation among other imaging ...

Employing this contrast-enhanced in-phase Dixon sequence may "help address a current challenge in routine clinical breast MRI interpretation," the authors of this AJR article concluded. Taylor-Cho, ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Elucirem, a macrocyclic gadolinium-based contrast agent for those aged 2 years and older, ...

MENLO PARK, Calif.--(BUSINESS WIRE)--HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, a global leader ...

Las Vegas, NV / Syndication Cloud / January 23, 2026 / ContrastConnect Key Takeaways CMS has permanently authorized ...

Contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with breast cancer who are unable to undergo MRI. “After NAT for ...

Contrast-enhanced in-phase Dixon sequence could reduce the need for correlation among other imaging modalities to better identify areas of prior biopsy during breast MRI interpretation, according to a ...